Hypersensitive reaction due to ferric carboxymaltose in a post-partum mother experienced in a tertiary care hospital in West Bengal, India: A case report

Iron deficiency anaemia (IDA) is highly associated with insufficient nutrition, chronic renal failure and congestive heart failure. Post-partum anaemia is also very common with a high mortality rate. Ferric carboxymaltose (FCM) is a non-dextran third-generation intravenous (IV)-iron preparation. FCM...

書誌詳細
出版年:	SAGE Open Medical Case Reports
主要な著者:	Arindam Halder, Bharat Chandra Mandi, Dattatreya Mukherjee, Aymar Akilimali
フォーマット:	論文
言語:	英語
出版事項:	SAGE Publishing 2024-10-01
オンライン･アクセス:	https://doi.org/10.1177/2050313X241290380

類似資料

A Case of Post‐Partum Afebrile Perforated Appendicitis: A Diagnostic Dilemma
著者:: Arindam Halder, 等
出版事項: (2025-02-01)

The experiences of ferric carboxymaltose desensitization and provocation
著者:: Fatma Dindar Çelik, MD, 等
出版事項: (2025-02-01)

Acute hypersensitivity reaction following intravenous ferric carboxymaltose injection for iron deficiency anaemia: a case report.
著者:: Neeraj Kumar, 等
出版事項: (2023-03-01)

Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
著者:: Melvin H. Seid, 等
出版事項: (2017-01-01)

Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia
著者:: Aysun Seker, 等
出版事項: (2025-01-01)

Incidence of Hypophosphatemia after Ferric Carboxymaltose Treatment: Single Center Experience
著者:: Esra TERZİ DEMİRSOY
出版事項: (2021-08-01)

Ferric Carboxymaltose in the Treatment of Anemia in Patients with Locally Advanced Colon Cancer
著者:: D. O. Kornev, 等
出版事項: (2025-04-01)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
著者:: Sakiyeva Kanshaiym, 等
出版事項: (2020-01-01)

Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing
著者:: Matthias Diebold, 等
出版事項: (2019-03-01)

Fatal anaphylactic reaction due to ferric carboxymaltose: A case report
著者:: Aylin Mualla Arici, 等
出版事項: (2020-07-01)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up
著者:: Antonio Lacquaniti, 等
出版事項: (2020-09-01)

Ferric carboxymaltose: A game changer in the management of iron deficiency anaemia in pregnancy
著者:: Nalini Sharma, 等
出版事項: (2024-06-01)

Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anaemia in Paediatric Patients with Anastomotic Ulcers
著者:: Chiara Udina, 等
出版事項: (2022-03-01)

P2 Intravenous ferric carboxymaltose for the treatment of refractory restless leg syndrome
著者:: Jasvinder Kaler, 等
出版事項: (2023-10-01)

Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction
著者:: Raquel López‐Vilella, 等
出版事項: (2022-02-01)

The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis
著者:: Antonio Lacquaniti, 等
出版事項: (2023-06-01)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
著者:: I. E. Emrich, 等
出版事項: (2020-07-01)

The use of parenteral application of ferric carboxymaltose in the prevention of iron deficiency anaemia in suckling piglets
著者:: M Svoboda, 等
出版事項: (2025-07-01)

Eligibility Criteria for Ferric Carboxymaltose in Women with Iron Deficiency in Obstetrics: An Algerian Expert Consensus
著者:: Rachida Aouameur, 等
出版事項: (2024-12-01)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
著者:: Vineet Mishra, 等
出版事項: (2018-01-01)

Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status
著者:: Wendy Fang, 等
出版事項: (2020-06-01)

Ferric carboxymaltose in reducing blood transfusions and infections after cardiac surgeryCentral MessagePerspective
著者:: Tuomas O. Kiviniemi, MD, PhD, 等
出版事項: (2024-12-01)

Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis
著者:: Burhanuddin Sohail Rangwala, 等
出版事項: (2024-12-01)

Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study
著者:: Anouk Pels, 等
出版事項: (2015-01-01)

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study
著者:: Tilmann Kramer, 等
出版事項: (2021-12-01)

Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding
著者:: Ahmed Hagras, 等
出版事項: (2022-12-01)

Hypophosphataemia risk associated with ferric carboxymaltose in heart failure: A pooled analysis of clinical trials
著者:: Giuseppe MC Rosano, 等
出版事項: (2023-04-01)

A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
著者:: Sandip Kumar Ghosh, 等
出版事項: (2024-04-01)

Expert Consensus on the Significance of Intravenous Iron using Ferric Carboxymaltose Perioperatively and in Elective Major Orthopedic Surgeries
著者:: Mohan Desai, 等
出版事項: (2024-06-01)

Computational Prediction of Tissue Iron Dynamics in Iron Deficiency Anemia Following Intravenous Ferric Carboxymaltose Therapy
著者:: Cao K, 等
出版事項: (2025-10-01)

Hypophoshatemia Incidence in Patients with Chronic Kidney Disease Treated with Intravenous Ferric Carboxymaltose and Factors Related to Hypophosphatemia
著者:: Abdullah Şumnu, 等
出版事項: (2020-09-01)

WCN24-2145 ACUTE EFFECT OF FERRIC CARBOXYMALTOSE ON OXIDATIVE STRESS IN NON-DIALYSIS CKD PATIENTS
著者:: Ana Maria Mehedinti, 等
出版事項: (2024-04-01)

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
著者:: Iftikhar Hussain, 等
出版事項: (2013-01-01)

Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial‐IRON trial
著者:: Enrique Santas, 等
出版事項: (2024-04-01)

Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy
著者:: Darlington O. Okonko, 等
出版事項: (2019-08-01)

Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
著者:: Lea Bombač Tavčar, 等
出版事項: (2023-12-01)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
著者:: Adkinson NF, 等
出版事項: (2017-09-01)

Changes in Cardiac Function and Exercise Capacity Following Ferric Carboxymaltose Administration in HFrEF Patients with Iron Deficiency
著者:: Anastasios Tsarouchas, 等
出版事項: (2025-08-01)

Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis
著者:: Ayesha Khan, 等
出版事項: (2025-01-01)

Effect of ferric carboxymaltose in the iron deficiency anemia patients undergoing cardiac surgery: A randomized clinical trial
著者:: Fateme Ramezani, 等
出版事項: (2024-05-01)